Rory McIlroy is no stranger to blown leads at the Masters. His evaporated four-stroke lead in 2011 remains one of the four largest final-round collapses in Masters history. Even still, a failure to ...
Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...
The rhythm is regular at a rate of 42 beats/min. The first five QRS complexes are wide (0.14 seconds), with no P waves seen before or after. However, a P wave appears immediately before the fifth QRS ...
GAINBRIDGE FIELDHOUSE. BACK TO YOU. THANKS, SHANNON. THE IOWA STATE MEN CAME INTO TODAY WITH A SHOT AT A TOP FOUR SEED FOR NEXT WEEK’S BIG 12 TOURNAMENT. THAT WOULD HAVE MEANT A BYE FOR THE FIRST AND ...
Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...
Welcome to the final 2025-26 installment of the Hotline’s Pac-12 men’s basketball power rankings. The next edition, tentatively slotted for early December, will reflect the hierarchy in a conference ...
Marks HeartBeam’s transition to commercial company Rapidly growing practice and highly engaged member population to enable broad adoption Enables efficient scaling of additional preventive cardiology ...
BOTTOM LINE: No. 12 Nebraska visits UCLA after Pryce Sandfort scored 32 points in Nebraska's 82-67 victory over the USC Trojans. The Bruins have gone 16-1 in home games. UCLA scores 77.8 points while ...
HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in a recent article that discussed its recognition as a Global IP and Technology ...
Drivers are facing slick travel early Wednesday as overnight rain and wintry mix left some roads coated with black ice. People are urged to slow down because the thin glaze made conditions hazardous ...
(RTTNews) - HeartBeam, Inc. (BEAT), a medical technology company, announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company's groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results